000 01262 a2200361 4500
005 20250517233800.0
264 0 _c20191010
008 201910s 0 0 eng d
022 _a1365-2893
024 7 _a10.1111/jvh.12987
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLafferty, Lise
245 0 0 _aUnderstanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison.
_h[electronic resource]
260 _bJournal of viral hepatitis
_c12 2018
300 _a1526-1532 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPatient Acceptance of Health Care
_xstatistics & numerical data
650 0 4 _aPrisoners
650 0 4 _aYoung Adult
700 1 _aRance, Jake
700 1 _aGrebely, Jason
700 1 _aLloyd, Andrew R
700 1 _aDore, Gregory J
700 1 _aTreloar, Carla
773 0 _tJournal of viral hepatitis
_gvol. 25
_gno. 12
_gp. 1526-1532
856 4 0 _uhttps://doi.org/10.1111/jvh.12987
_zAvailable from publisher's website
999 _c28762758
_d28762758